Back close

Course Detail

Course Name Pharmacotherapeutics-II
Campus

Syllabus

UNIT- I Infectious disease 22 hrs

  • Guidelines for rational use of antibiotics and surgical prophylaxis 2 hrs
  • Septicaemia 2 hrs
  • Respiratory Tract infections: Pneumonia, Influenza, Bronchitis 3 hrs
  • Tuberculosis 2 hrs
  • UTI 2 hrs
  • Malaria 2 hrs
  • Meningitis 2 hrs
  • Endocarditis 2 hrs
  • HIV&Opportunistic infections 2 hrs
  • Fungal infections: Candidiasis, Aspergillosis, Dermatophytosis 3 hrs

UNIT- II Musculoskeletal disorders 10 hrs

  • Rheumatoid Arthritis 2hrs
  • Osteoarthritis 2hrs
  • Gout 2hrs
  • Systemic lupus erythematosus 2hrs
  • Spondylitis 2hrs

UNIT-III Central Nervous System 7 hrs

  • Alzheimer’s Disease 2hrs
  • Parkinson Disease 2hrs
  • Epilepsy 2 hrs
  • Artificial Intelligence in Neurological disorder managements 1 hr

UNIT-IV Psychiatric Disorders 11 hrs

  • Schizophrenia 3hrs
  • Affective Disorders 2hrs
  • Anxiety Disorders 2hrs
  • Sleep Disorders 2hrs
  • Obsessive Compulsive Disorders 2hrs

Objectives and Outcomes

SCOPE:This course is designed to impart knowledge and skills necessary for the rational use of medicines. It provides an opportunity to learn and analyse pharmacotherapeutic management and its applications in various diseases including recent advances, approved treatment algorithms, and guidelines. It provides insight into the rationale behind medication selection for managing diseases as well as the role of pharmacological and non-pharmacological therapies to optimize patient care. Additionally, this course emphasizes understanding, identifying, evaluating, and preventing a variety of drug-related issues. Recent advances in pharmacotherapy and patient-specific management strategies are included and emphasized. The course emphasizes student-directed acquisition of necessary knowledge in the management of various diseases using AI approach.(SDG 4)This course also, highlighting the importance of evidence-based decision-making in selecting the most effective medications for individual patients. Students will develop critical thinking skills to evaluate the risks and benefits of pharmacological treatments, ensuring that pharmacotherapy is tailored to optimize therapeutic outcomes and minimize adverse effects. By promoting safe, effective, and individualized treatment strategies, this course contributes to improving overall patient health and supports the goal of universal access to quality healthcare. (SDG 3)COURSE LEARNING OUTCOMES:Upon successful completion of the course, students shall be able to:KNOWLEDGEK1: Identify clinical manifestations and complications of specified diseases to guide pharmacotherapeutic decision-making.K2: Describe the importance of differential diagnosis in the effective management of medical conditionsK3: Discuss the patient-specific parameters relevant to initiating and continuing drug therapy (including alternatives, time-course of clinical and laboratory indices of therapeutic response, and adverse effects)K4: Explain non-pharmacological and pharmacological approaches for the management of various diseasesK5: Illustrate standard treatment guidelines used for various diseases/disordersK6: Correlate the rationale behind the use of the current treatment algorithm for the management of various diseasesSKILLS1: Compare the patient?s current treatment regimen with the approved treatment algorithm for the management of various diseasesS2: Demonstrate the ability to recognize various drug-related problemsS3: Justify the rationale for changes in drug therapy and patients’ clinical outcomesS4: Demonstrate effective patient counselling skills in the clinical setting.S5: Apply the pharmacological knowledge in the prevention and treatment of various disordersS6: Solve the various drug-related problems in the patient drug therapyATTITUDEA1: Communicate effectively with patients and other healthcare professionals A2: Exhibit professionalism in all the clinical activitiesA3: Display sincerity, punctuality, and integrity in all the academic and non-academic activitiesA4: Support and collaborate with various stakeholdersA5: Follow the ethical values in maintaining the confidentiality of patient informationA6: Appreciate the effective reporting of drug-related problems among healthcare professionalLECTURE WISE CONTENTS:Introduction to disease or disorders, Differential Diagnosis, Therapeutic goals, Non pharmacological and Pharmacological management including treatment algorithm & latest guidelines. Recent advancements associated with following diseases

Text Books / References

TEXT BOOKS:

  • Walker, Clinical Pharmacy and Therapeutics.5th ed. Edinburgh: Churchill Living Stone publication;2012
  • Dipiro Pharmacotherapy: A Pathophysiologic approach. 11thed.NewYork: McGraw Hill;2017.
  • Clinical Pharmacy and Therapeutics.5th ed. Philadelphia: LPWW;1988
  • Robbins and Pathologic basis of disease. 8th ed. Philadelphia: Elsevier;2003

REFERENCE BOOKS:

  • Kodak-Kimble, Mary Applied Therapeutics: The Clinical Use of Drugs. 11th ed. Philadelphia: LPWW;2009
  • Porth’s Essentials of 5thed, Philadelphia: LPWW;2011
  • Brunton L, Lazo Goodman & Gilman’s The Pharmacological Basis of Therapeutics. 13th ed. New York: McGraw Hill;2006

DISCLAIMER: The appearance of external links on this web site does not constitute endorsement by the School of Biotechnology/Amrita Vishwa Vidyapeetham or the information, products or services contained therein. For other than authorized activities, the Amrita Vishwa Vidyapeetham does not exercise any editorial control over the information you may find at these locations. These links are provided consistent with the stated purpose of this web site.

Admissions Apply Now